Advertisement

Topics

Cambridge Research Biochemicals supports evaluation of new Fuchs Dystrophy treatment

10:49 EDT 23 May 2018 | EPM Magazine

Cambridge Research Biochemicals has announced that under the terms of a new contract with Leidos Biomedical Research, it will support the evaluation of a new treatment approach for Fuchs Dystrophy

Original Article: Cambridge Research Biochemicals supports evaluation of new Fuchs Dystrophy treatment

NEXT ARTICLE

More From BioPortfolio on "Cambridge Research Biochemicals supports evaluation of new Fuchs Dystrophy treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...